- Althea Group's subsidiary MyAccess Clinics Group has received a licence from the Care Quality Commission
- This is a significant milestone as it provides more acceptance of hemp-based medicines being used in the United Kingdom
- MyAccess Clinics is only the second medical hemp clinic in the U.K. to receive the licence
- Yesterday Althea entered an agreement with an Australian hemp centre to supply its product for a clinical trial
- Althea's share price is up 4.21 per cent with shares trading for 49.5 cents each
Click here for the entire article on The Market Herald
MyAccess Clinics secures licence with UK health regulator
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
2.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.90M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500000 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 100000 | 1 |
View Market Depth
| Last trade - 14.53pm 15/09/2025 (20 minute delay) ? |
| AGH (ASX) Chart |
Day chart unavailable